Congressional Testimony of Presidential Advisers (CRS)
The suggestion that it would be inherently inappropriate for presidential advisers to testify under oath before Congress regarding the firing of U.S. attorneys was swiftly batted down with numerous references to a 2004 Congressional Research Service report (pdf) on the subject.
CRS analyst Harold C. Relyea identified dozens of cases in which presidential advisers had been summoned to testify to Congress, and did so. See “Presidential Advisers’ Testimony Before Congressional Committees: A Brief Overview,” April 14, 2004.
The United States needs a strategic investment fund (SIF) to shepherd promising technologies in nationally vital sectors through the valley of death.
Standardizing support for Accessibility & Accommodations in federally funded research efforts would open opportunities for disabled scientists and their research programs.
The incoming administration must act to address bias in medical technology at the development, testing and regulation, and market-deployment and evaluation phases.
Increasingly, U.S. national security priorities depend heavily on bolstering the energy security of key allies, including developing and emerging economies. But U.S. capacity to deliver this investment is hamstrung by critical gaps in approach, capability, and tools.